Nancy A Rigotti1, Susan Regan2, Douglas E Levy3, Sandra Japuntich4, Yuchiao Chang5, Elyse R Park6, Joseph C Viana7, Jennifer H K Kelley8, Michele Reyen9, Daniel E Singer5. 1. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston2Division of General Internal Medicine, Medical Service, Massachusetts General Hospital, Boston3Mongan Institute for Health Policy, Massachusetts General Hospital and Partners He. 2. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston2Division of General Internal Medicine, Medical Service, Massachusetts General Hospital, Boston4Department of Medicine, Harvard Medical School, Boston, Massachusetts. 3. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston3Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston4Department of Medicine, Harvard Medical School, Boston, Massachusetts. 4. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston5National Center for PTSD, VA Boston Healthcare System, Boston, Massachusetts6Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts. 5. Division of General Internal Medicine, Medical Service, Massachusetts General Hospital, Boston4Department of Medicine, Harvard Medical School, Boston, Massachusetts. 6. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston3Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston7Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. 7. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston8Department of Health Policy and Management, University of California, Los Angeles. 8. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston3Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston. 9. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston2Division of General Internal Medicine, Medical Service, Massachusetts General Hospital, Boston.
Abstract
IMPORTANCE: Health care systems need effective models to manage chronic diseases like tobacco dependence across transitions in care. Hospitalizations provide opportunities for smokers to quit, but research suggests that hospital-delivered interventions are effective only if treatment continues after discharge. OBJECTIVE: To determine whether an intervention to sustain tobacco treatment after hospital discharge increases smoking cessation rates compared with standard care. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial compared sustained care (a postdischarge tobacco cessation intervention) with standard care among 397 hospitalized daily smokers (mean age, 53 years; 48% were males; 81% were non-Hispanic whites) who wanted to quit smoking after discharge and received atobacco dependence interventionin the hospital; 92% of eligible patients and 44% of screened patients enrolled. The study was conducted from August 2010 through November 2012 at Massachusetts General Hospital. INTERVENTIONS: Sustained care participants received automated interactive voice response telephone calls and their choice of free smoking cessation medication (any type approved by the US Food and Drug Administration) for up to 90 days. The automated telephone calls promoted cessation, provided medication management, and triaged smokers for additional counseling. Standard care participants received recommendations for postdischarge pharmacotherapy and counseling. MAIN OUTCOMES AND MEASURES: The primary outcome was biochemically confirmed past 7-day tobacco abstinence at 6-month follow-up after discharge from the hospital; secondary outcomes included self-reported tobacco abstinence. RESULTS: Smokers randomly assigned to sustained care (n = 198) used more counseling and more pharmacotherapy at each follow-up assessment than those assigned to standard care (n = 199). Biochemically validated 7-day tobacco abstinence at 6 months was higher with sustained care (26%) than with standard care (15%) (relative risk [RR], 1.71 [95% CI, 1.14-2.56], P = .009; number needed to treat, 9.4 [95% CI, 5.4-35.5]). Using multiple imputation for missing outcomes, the RR for 7-day tobacco abstinence was 1.55 (95% CI, 1.03-2.21; P = .04). Sustained care also resulted in higher self-reported continuous abstinence rates for 6 months after discharge (27% vs 16% for standard care; RR, 1.70 [95% CI, 1.15-2.51]; P = .007). CONCLUSIONS AND RELEVANCE: Among hospitalized adult smokers who wanted to quit smoking, a postdischarge intervention providing automated telephone calls and free medication resulted in higher rates of smoking cessation at 6 months compared with a standard recommendation to use counseling and medication after discharge. These findings, if replicated, suggest an approach to help achieve sustained smoking cessation after a hospital stay. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01177176.
RCT Entities:
IMPORTANCE: Health care systems need effective models to manage chronic diseases like tobacco dependence across transitions in care. Hospitalizations provide opportunities for smokers to quit, but research suggests that hospital-delivered interventions are effective only if treatment continues after discharge. OBJECTIVE: To determine whether an intervention to sustain tobacco treatment after hospital discharge increases smoking cessation rates compared with standard care. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial compared sustained care (a postdischarge tobacco cessation intervention) with standard care among 397 hospitalized daily smokers (mean age, 53 years; 48% were males; 81% were non-Hispanic whites) who wanted to quit smoking after discharge and received a tobacco dependence intervention in the hospital; 92% of eligible patients and 44% of screened patients enrolled. The study was conducted from August 2010 through November 2012 at Massachusetts General Hospital. INTERVENTIONS: Sustained care participants received automated interactive voice response telephone calls and their choice of free smoking cessation medication (any type approved by the US Food and Drug Administration) for up to 90 days. The automated telephone calls promoted cessation, provided medication management, and triaged smokers for additional counseling. Standard care participants received recommendations for postdischarge pharmacotherapy and counseling. MAIN OUTCOMES AND MEASURES: The primary outcome was biochemically confirmed past 7-day tobacco abstinence at 6-month follow-up after discharge from the hospital; secondary outcomes included self-reported tobacco abstinence. RESULTS: Smokers randomly assigned to sustained care (n = 198) used more counseling and more pharmacotherapy at each follow-up assessment than those assigned to standard care (n = 199). Biochemically validated 7-day tobacco abstinence at 6 months was higher with sustained care (26%) than with standard care (15%) (relative risk [RR], 1.71 [95% CI, 1.14-2.56], P = .009; number needed to treat, 9.4 [95% CI, 5.4-35.5]). Using multiple imputation for missing outcomes, the RR for 7-day tobacco abstinence was 1.55 (95% CI, 1.03-2.21; P = .04). Sustained care also resulted in higher self-reported continuous abstinence rates for 6 months after discharge (27% vs 16% for standard care; RR, 1.70 [95% CI, 1.15-2.51]; P = .007). CONCLUSIONS AND RELEVANCE: Among hospitalized adult smokers who wanted to quit smoking, a postdischarge intervention providing automated telephone calls and free medication resulted in higher rates of smoking cessation at 6 months compared with a standard recommendation to use counseling and medication after discharge. These findings, if replicated, suggest an approach to help achieve sustained smoking cessation after a hospital stay. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01177176.
Authors: Sophia Papadakis; Paul W McDonald; Andrew L Pipe; Scott T Letherdale; Robert D Reid; K Stephen Brown Journal: Prev Med Date: 2013-02-26 Impact factor: 4.018
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Nancy A Rigotti; Yuchiao Chang; Lisa C Rosenfeld; Sandra J Japuntich; Elyse R Park; Hilary A Tindle; Douglas E Levy; Zachary Z Reid; Joanna Streck; Timothy Gomperts; Jennifer H K Kelley; Daniel E Singer Journal: J Gen Intern Med Date: 2017-06-14 Impact factor: 5.128
Authors: Kathleen B Cartmell; Mary Dooley; Martina Mueller; Georges J Nahhas; Clara E Dismuke; Graham W Warren; Vince Talbot; K Michael Cummings Journal: Med Care Date: 2018-04 Impact factor: 2.983
Authors: Susan Regan; Zachary Z Reid; Jennifer H K Kelley; Michele Reyen; Molly Korotkin; Sandra J Japuntich; Joseph C Viana; Douglas E Levy; Nancy A Rigotti Journal: Nicotine Tob Res Date: 2015-04-06 Impact factor: 4.244
Authors: Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh Journal: Circulation Date: 2016-11-13 Impact factor: 29.690
Authors: Nancy A Rigotti; Kathleen F Harrington; Kimber Richter; Jeffrey L Fellows; Scott E Sherman; Ellie Grossman; Yuchiao Chang; Hilary A Tindle; Thomas Ylioja Journal: Nicotine Tob Res Date: 2014-08-28 Impact factor: 4.244
Authors: Eric W Tai; Gery P Guy; C Brooke Steele; S Jane Henley; Michael S Gallaway; Lisa C Richardson Journal: Am J Prev Med Date: 2018-02-01 Impact factor: 5.043
Authors: Christi A Patten; Harry A Lando; Chris A Desnoyers; Yvette Barrows; Joseph Klejka; Paul A Decker; Christine A Hughes; Martha J Bock; Rahnia Boyer; Kenneth Resnicow; Linda Burhansstipanov Journal: Contemp Clin Trials Date: 2019-01-28 Impact factor: 2.226